Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon

Apply

Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon

Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2014, Vol 2, Issue 4

Abstract

Purpose: To compare the outcomes after switching from intravitreal bevacizumab (IVB) to intravitreal ranibizumab (IVR) in patients with neovascular age related macular degeneration (ARMD). Material and Methods: A retrospective review of patients with neovascular ARMD, who were switched from treatment with Pro Re Nata (PRN) IVB to PRN IVR, was conducted in a university clinic. IVB (1.25 mg/0.05 ml) and IVR (0.5 mg/0.05 ml) were used. Retreatment criteria were defined based on an activity scoring (AS) system developed in our clinic. An AS was calculated for each lesion at each visit. AS results and the number of injections before and after switching treatment to IVR were compared.

Authors and Affiliations

Nilay Yuksel

Keywords

Activity Scoring; Age Related Macular Degeneration; Bevacizumab; Ranibizumab.

Endophthalmitis Vitrectomy Study: Effectiveness of Guidelines in Cases of Endophthalmitis Following Manual Small Incision Cataract Surgery

Objective: To validate Endophthalmitis vitrectomy study guidelines in cases of post-operative endophthalmitis following Manual small incision cataract surgery. Setting: Tertiary eye care centre in western central India P...

Human Umbilical Cord Blood Stem Cells Differentiate into Keratinocytes under In Vitro Conditions and Culturing Differentiated Cells on Bacterial Cellulose Film

Mesenchymal stem cells (MSC) are capable of self renewing and differentiating into other cell types. Human umbilical cord blood (HUCB) has been investigated as an alternative source to bone marrow. The aim of our examina...

EP ID EP197547
DOI 10.19070/2332-290X-140007
Views 91
Downloads 0